Kolexia
Taillibert Sophie
Neurologie
Hôpital Pitie Salpetriere
Paris, France
77 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Métastase tumorale Tumeurs du cerveau Tumeurs du sein Glioblastome Méningite Tumeurs des méninges Gliome Méningite carcinomateuse Tumeurs du poumon

Industries

Roche
1 collaboration(s)
Dernière en 2016
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Phase II study of intrathecal administration of trastuzumab in patients with HER2-positive breast cancer with leptomeningeal metastasis.
Neuro-oncology   15 février 2023
The Impact of Tumor Treating Fields on Glioblastoma Progression Patterns.
International journal of radiation oncology, biology, physics   26 décembre 2021
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial.
JAMA oncology   13 septembre 2019
HIT: Phase 1-2 Study of Safety and Efficacy of Intrathecal Trastuzumab Administration in Metastatic HER2 Positive Breast Cancer Patients Developing Carcinomatous Meningitis
Essai Clinique (Institut Curie)   09 juillet 2019
CMET-39. INTRA-CSF LIPOSOMAL CYTARABINE PLUS SYSTEMIC THERAPY AS INITIAL TREATMENT OF BREAST CANCER LEPTOMENINGEAL METASTASIS: A RANDOMISED, OPEN-LABEL TRIAL
Abstracts from the 23rd Annual Scientific Meeting and Education Day of the Society for Neuro-Oncology November 15 – 18, 2018 New Orleans, Louisiana   05 novembre 2018
Intra-CSF liposomal cytarabine plus systemic therapy as initial treatment of breast cancer leptomeningeal metastasis: A randomised, open-label trial
Abstract Book of the 43rd ESMO Congress (ESMO 2018) 19–23 October 2018, Munich, Germany   01 octobre 2018
Leptomeningeal metastasis.
Handbook of clinical neurology   26 juillet 2018
Phase I feasibility study for intrathecal administration of trastuzumab in patients with HER2 positive breast carcinomatous meningitis.
European journal of cancer (Oxford, England : 1990)   07 avril 2018
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial.
JAMA   08 janvier 2018
Leptomeningeal metastases: a RANO proposal for response criteria.
Neuro-oncology   20 décembre 2017